Venous Leg Ulcer

4
Pipeline Programs
6
Companies
11
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
1
Concurrent optical and magnetic stimulationPhase 41 trial
Active Trials
NCT06528873Not Yet RecruitingEst. Sep 2026
Organogenesis
OrganogenesisCANTON, MA
2 programs
1
DermagraftPhase 31 trial
AffinityN/A1 trial
Active Trials
NCT04901013UnknownEst. Jun 2023
NCT00909870CompletedEst. Aug 2011
MediWound
MediWoundYAVNE, Israel
2 programs
2
EscharExPhase 21 trial
EscharExPhase 21 trial
Active Trials
NCT04817228Completed12Est. May 2022
NCT03588130Completed120Est. Mar 2022
ConvaTec
ConvaTecNJ - Bridgewater
2 programs
AQUACEL® Ag+ Extra™N/A1 trial
AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®N/A1 trial
Active Trials
NCT05892341CompletedEst. Feb 2024
NCT07308678CompletedEst. May 2025
C
ColoplastAustralia - Mulgrave
2 programs
Biatain Fiber Ag applied to participantsN/A1 trial
Biatain® SiliconeN/A1 trial
Active Trials
NCT05873257CompletedEst. May 2024
NCT05786612CompletedEst. Dec 2023
Tactile Medical
Tactile MedicalMN - Minneapolis
2 programs
Dual Action Pneumatic CompressionN/A1 trial
Dual Action Pneumatic Compression DeviceN/A1 trial
Active Trials
NCT02395302Completed28Est. Nov 2015
NCT02680834Terminated56Est. Jun 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
T-TherapeuticsConcurrent optical and magnetic stimulation
OrganogenesisDermagraft
MediWoundEscharEx
MediWoundEscharEx
ConvaTecAQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®
ColoplastBiatain Fiber Ag applied to participants
ColoplastBiatain® Silicone
ConvaTecAQUACEL® Ag+ Extra™
OrganogenesisAffinity
Tactile MedicalDual Action Pneumatic Compression Device
Tactile MedicalDual Action Pneumatic Compression

Clinical Trials (11)

Total enrollment: 216 patients across 11 trials

NCT06528873T-TherapeuticsConcurrent optical and magnetic stimulation

COMS for Chronic Ulcers Treatment

Start: Jun 2025Est. completion: Sep 2026
Phase 4Not Yet Recruiting

Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers

Start: Jun 2009Est. completion: Aug 2011
Phase 3Completed

A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers

Start: Apr 2021Est. completion: May 202212 patients
Phase 2Completed

A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers

Start: Dec 2019Est. completion: Mar 2022120 patients
Phase 2Completed
NCT07308678ConvaTecAQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®

AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®

Start: Apr 2025Est. completion: May 2025
N/ACompleted
NCT05873257ColoplastBiatain Fiber Ag applied to participants

Investigation of the Clinical Performance of Biatain Fiber Ag on Venous Leg Ulcers

Start: Jul 2023Est. completion: May 2024
N/ACompleted
NCT05786612ColoplastBiatain® Silicone

Clinical Performance and Cost Effectiveness of Biatain® Silicone Compared With Standard of Care

Start: Jan 2023Est. completion: Dec 2023
N/ACompleted
NCT05892341ConvaTecAQUACEL® Ag+ Extra™

AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period

Start: Dec 2022Est. completion: Feb 2024
N/ACompleted

Clinical Study Of Affinity Versus SOC In The Management Of VLUs

Start: Jun 2021Est. completion: Jun 2023
N/AUnknown
NCT02680834Tactile MedicalDual Action Pneumatic Compression Device

VLU Non-Inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-Layer Bandaging

Start: Feb 2016Est. completion: Jun 201756 patients
N/ATerminated
NCT02395302Tactile MedicalDual Action Pneumatic Compression

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)

Start: Dec 2014Est. completion: Nov 201528 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
6 companies competing in this space